bioRxiv / medRxiv
open access
CC BY-NC-ND 4.0
AI-Driven Design of Nanobinders Targeting the TSLPR Heterodimer Interface to Suppress Type 2 Inflammatory Signaling
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Editorial: Advances in biomarkers and drug targets: harnessing traditional and AI approaches for novel therapeutic mechanisms.#360663
- A tissue-intrinsic mechanism sensitizes HIV-1 particles for TLR-triggered innate immune responses.#172050
- The SLC15A4–TASL complex is essential for lupus development in mice#796310
- Testing if PDR-001 Can Safely and Effectively Remove Harmful Brain Protein in Parkinson's Disease#1126794
- Polymeric particle-based therapies for acute inflammatory diseases#1174818
Record · ID 471356
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive